• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SECONDARY SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SECONDARY SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 72213N
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/27/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd alaris secondary set was leaking the following information was received by the initial reporter with the following verbatim: we had a line leak while administering ivig.
 
Event or Problem Description
No additional information was provided.
 
Additional Manufacturer Narrative
The customer reported leakage, and returned one sample of material 72213n, lot 24033126.Upon initial visual examination, the set had no defects or abnormalities, just some staining from the medication used.The set was left to infuse water, but the leakage was not replicated.Further examination of the spike vent cap was found to be potential the issue.The vent cap was examined under microscope for issues.The manufacturing site used the vent cap issue to try and identify the root cause.There was not a definitive root cause found.Potential root cause relates to the training of personnel, and the process involved.All staff were notified of the issue.Device history record review for model 72213n lot number 24033126 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 07mar2024.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.Your assistance in this matter has been helpful in trend identification and supporting our commitment to continuous quality improvement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS SECONDARY SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19570392
Report Number9616066-2024-00908
Device Sequence Number6974496
Product Code FPA
UDI-Device Identifier07613203010078
UDI-Public(01)07613203010078
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K022209
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number72213N
Device Lot Number24033126
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/28/2024
Supplement Date Received by Manufacturer08/15/2024
Initial Report FDA Received Date06/19/2024
Supplement Report FDA Received Date08/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-